Gynodaktarin (miconazole nitrate) for vulvovaginal candidiasis.
A new potent fungicidal preparation, miconazole nitrate 2 percent (Gynodaktarin) was used in 40 patients, both pregnant, with vulvovaginal candidiasis. It was as effective in pregnant as in non-pregnant patients. Retreatment in three cases of recurrence was successful. There were no side effects reported, and the drug was found to be safe for pregnant patients and their offspring.
D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D008825:Miconazole / Q000009:adverse effects / Q000627:therapeutic use*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D012008:Recurrence
D007093:Imidazoles; D008825:Miconazole